Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dynegy Inc
DYN | US
18.26
USD-0.64
-3.39%
DYN | US
Loading StockChartView...
About Dynegy Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
18.26
Open
19.00
High
19.16
Low
18.11
Dyne Therapeutics Inc. a muscle disease company operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1 duchenne muscular dystrophy and facioscapulohumeral dystrophy as well as rare skeletal muscle and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics Inc. was incorporated in 2017 and is headquartered in Waltham Massachusetts.
View LessDYN | US
Risk
58.7
Sharpe
0.75
Luna's Score
45/100
Recommendation
Sell
Luna says (DYN | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
47.8%1 month
58.7%3 months
70.8%6 months
93.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.56
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-8.87
Ent. to rev.
-
PEG
0.19
Other Fundamentals
EBITDA
-269.47M
MarketCap
1.83B
MarketCap(USD)
1.83B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-52.46
Short ratio
4.43
Short perc.
10.53
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
3.31
Range1M
4.56
Range3M
7.43
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.65
Price X volume
21.26M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.87 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.56 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 70.81 | 72.80 | Par |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.03 | 0.25 | Cheaper |
| Market Cap | 1.83B | 3.66B | Emerging |
